Silverarc Capital Management as of Dec. 31, 2025
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 68 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 7.9 | $57M | 422k | 134.85 | |
| Cogent Biosciences (COGT) | 6.1 | $44M | 1.2M | 35.52 | |
| Urogen Pharma (URGN) | 5.7 | $41M | 1.7M | 23.42 | |
| Kalvista Pharmaceuticals (KALV) | 5.4 | $39M | 2.4M | 16.15 | |
| Celcuity (CELC) | 5.2 | $37M | 375k | 99.74 | |
| Nuvalent Inc-a (NUVL) | 4.4 | $31M | 311k | 100.59 | |
| Dianthus Therapeutics (DNTH) | 4.3 | $31M | 750k | 41.21 | |
| Kodiak Sciences (KOD) | 4.0 | $29M | 1.0M | 27.96 | |
| Praxis Precision Medicines I Com New (PRAX) | 3.4 | $24M | 83k | 294.74 | |
| Immunome (IMNM) | 3.4 | $24M | 1.1M | 21.48 | |
| Fractyl Health (GUTS) | 3.0 | $22M | 9.8M | 2.20 | |
| Uniqure Nv Call Call Option | 2.4 | $17M | 721k | 23.93 | |
| Monte Rosa Therapeutics (GLUE) | 2.2 | $16M | 1.0M | 15.68 | |
| Veracyte (VCYT) | 2.1 | $15M | 358k | 42.10 | |
| Cg Oncology (CGON) | 2.1 | $15M | 361k | 41.52 | |
| Rhythm Pharmaceuticals (RYTM) | 2.0 | $15M | 136k | 107.04 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $14M | 643k | 21.01 | |
| Biogen Idec (BIIB) | 1.8 | $13M | 75k | 175.99 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $12M | 71k | 174.04 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.6 | $12M | 458k | 25.01 | |
| Miragen Therapeutics (VRDN) | 1.5 | $11M | 349k | 31.12 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.5 | $11M | 49k | 213.24 | |
| Pfizer (PFE) | 1.4 | $10M | 419k | 24.90 | |
| Benitec Biopharma Com New (BNTC) | 1.4 | $9.9M | 732k | 13.47 | |
| Avalo Therapeutics Com New (AVTX) | 1.3 | $9.5M | 524k | 18.16 | |
| Guardant Health (GH) | 1.3 | $9.4M | 92k | 102.14 | |
| Oric Pharmaceuticals (ORIC) | 1.3 | $9.1M | 1.1M | 8.18 | |
| Vaxcyte (PCVX) | 1.0 | $6.9M | 149k | 46.14 | |
| Trevi Therapeutics (TRVI) | 0.9 | $6.8M | 541k | 12.52 | |
| Gossamer Bio (GOSS) | 0.9 | $6.6M | 2.1M | 3.10 | |
| Spyre Therapeutics Com New (SYRE) | 0.9 | $6.2M | 188k | 32.76 | |
| Lexeo Therapeutics (LXEO) | 0.9 | $6.1M | 618k | 9.93 | |
| Amylyx Pharmaceuticals (AMLX) | 0.8 | $6.1M | 506k | 12.08 | |
| Cerus Corporation (CERS) | 0.8 | $5.8M | 2.8M | 2.06 | |
| Compass Therapeutics (CMPX) | 0.8 | $5.6M | 1.1M | 5.37 | |
| Soleno Therapeutics (SLNO) | 0.8 | $5.4M | 118k | 46.30 | |
| Compugen Ord (CGEN) | 0.7 | $5.3M | 3.5M | 1.53 | |
| Celldex Therapeutics Com New (CLDX) | 0.7 | $5.2M | 191k | 27.16 | |
| Olema Pharmaceuticals (OLMA) | 0.7 | $5.2M | 206k | 25.00 | |
| Erasca (ERAS) | 0.7 | $4.9M | 1.3M | 3.72 | |
| Kalvista Pharmaceuticals Call Call Option | 0.7 | $4.7M | 291k | 16.15 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $4.5M | 395k | 11.31 | |
| Fulcrum Therapeutics Call Call Option | 0.6 | $4.4M | 392k | 11.31 | |
| Aardvark Therapeutics (AARD) | 0.6 | $4.0M | 304k | 13.12 | |
| C4 Therapeutics Com Stk (CCCC) | 0.5 | $3.8M | 2.0M | 1.91 | |
| Surrozen Com New (SRZN) | 0.5 | $3.6M | 157k | 22.60 | |
| Contineum Therapeutics Cl A (CTNM) | 0.5 | $3.5M | 308k | 11.43 | |
| Mineralys Therapeutics (MLYS) | 0.5 | $3.4M | 95k | 36.29 | |
| Relay Therapeutics (RLAY) | 0.5 | $3.4M | 398k | 8.46 | |
| Abeona Therapeutics Com New (ABEO) | 0.5 | $3.3M | 628k | 5.27 | |
| Tela Bio (TELA) | 0.4 | $3.1M | 2.6M | 1.18 | |
| Uniqure Nv SHS (QURE) | 0.4 | $3.0M | 126k | 23.93 | |
| Tarsus Pharmaceuticals (TARS) | 0.4 | $3.0M | 36k | 81.88 | |
| Kymera Therapeutics (KYMR) | 0.4 | $2.7M | 35k | 77.81 | |
| Ultragenyx Pharmaceutical In Call Call Option | 0.4 | $2.5M | 110k | 23.00 | |
| Nextcure Com New (NXTC) | 0.3 | $2.5M | 176k | 14.19 | |
| Elutia Cl A Com (ELUT) | 0.3 | $1.9M | 2.8M | 0.69 | |
| Sionna Therapeutics (SION) | 0.2 | $1.7M | 42k | 41.14 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $1.6M | 386k | 4.26 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.2 | $1.4M | 357k | 4.00 | |
| Edgewise Therapeutics (EWTX) | 0.1 | $1.0M | 42k | 24.82 | |
| Radiopharm Theranostics Sponsored Ads (RADX) | 0.1 | $978k | 187k | 5.22 | |
| 4d Molecular Therapeutics In (FDMT) | 0.1 | $750k | 100k | 7.50 | |
| Adagio Med Hldgs (ADGM) | 0.1 | $536k | 515k | 1.04 | |
| Rapport Therapeutics (RAPP) | 0.0 | $293k | 9.7k | 30.34 | |
| Palisade Bio (PALI) | 0.0 | $240k | 102k | 2.35 | |
| Ibio Com New (IBIO) | 0.0 | $205k | 106k | 1.93 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $2.5k | 105k | 0.02 |
